Skip to main content

US ClosedU.S. Closed

MYGN: Myriad Genetics, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Myriad Genetics, Inc. , a molecular diagnostics and precision medicine company, develops molecular tests.

52W Range

7thpctl

Volume

0.78×avg

Market Cap

298.46MUSD

P/E Ratio

-2.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

$3.16

−0.63%

$3.16

−$0.02 (0.63%)

52W Range

7thpctl

Volume

0.78×avg

Mkt Cap

298.46MUSD

P/E

-2.6TTM

Div Yield

–ann